Morning all,

Obesity is back in the headlines – this time with the government investing millions in a partnership with Mounjaro supplier Lilly to roll out weight-loss jabs across the country.

Cancer, too, has dominated the news, from prostate cancer warnings and pancreatic cancer vaccine trials to concerning drops in survival rates. I dive into what the latest findings mean for patients below.

Maternity care remains a key focus for The Independent. My colleague Rachel Schraer reports on a country that successfully overcame a maternal death crisis – and how Donald Trump’s aid cuts now threaten that progress.

Finally, readers familiar with long A&E waits will understand the frustration, but this week the Royal College of Nursing highlighted another alarming issue: the rising rates of violence nurses face while on duty.

See you next week.

Top health headlines

Walking science unlocked: the daily step count for different benefits

By Harry Bullmore

Ham sold in Tesco and M&S found to contain cancer-causing chemicals

By Rebecca Whittaker

NHS official admits ‘what we did wasn’t enough’ for girl who died

By Rebecca Thomas

The spicy favorite that can help protect your vision and your heart

By Julia Musto

Letby’s hospital slammed for A&E failings

By Rebecca Thomas

Living Well

Awareness of health conditions often spikes when prominent figures speak out. We’ve seen this with Dame Deborah James and bowel cancer, and more recently with Sir Chris Hoy and prostate cancer.

Since his diagnosis, Sir Chris has campaigned for a better screening programme for men. Last year, the government asked its national screening committee to review current policies, with results expected later this year.

The committee could recommend a range of options – from leaving the programme as it is, to targeting high-risk groups, or rolling it out more widely. Early indications suggest the first and last options are less likely.

Whatever the outcome, there will be implications for the NHS. One concern is the risk of over-treatment, which can accompany increased awareness – a positive development, but not without challenges.

Unlike some cancers, certain prostate cancers are very low risk and may never spread. Current research suggests that for these cases, “active monitoring” rather than surgery or other interventions is usually the safest approach.

Thousands of men with prostate cancer facing unnecessary overtreatment, experts warn

Experts suggest ‘outdated guidelines’ around prostate cancer have created a ‘wild west’ of what is implemented in the NHS

This week, Prostate Cancer UK